Increasing capacity for genomic analysis: apply for funding

20 Jun 2018 01:53 PM

Businesses can apply for a share of up to £5 million to support investment in equipment that increases the UK's capacity to carry out genomic analysis.

Innovate UK has up to £5 million to support capital investment in equipment that increases the UK’s capacity to produce and commercialise genomic analysis technologies.

Genomic analysis can help in the understanding and treatment of diseases such as heart disease, diabetes and cancer.

The funding is part of government’s £210 million data to early diagnosis and precision medicine challenge under its Industrial Strategy Challenge Fund. The funding is provided by UK Research and Innovation and delivered by Innovate UK.

The aim of the challenge is to help business and researchers to create new products and services that diagnose diseases earlier and more efficiently.

Find out more about the data to early diagnosis and precision medicine challenge.

Projects should help take new products to market

Funding under this competition aims to help businesses working in genomic analysis, nucleic-acid-based diagnostics and related areas by supporting investment in equipment that will help them take new products to market.

Projects must demonstrate that the investment will:

Projects should have a clear plan of how the capital investment will lead to the translation and commercialisation of research including manufacture of new products.

Equipment manufactured could be laboratory-based or deployable in the field.

Competition information

Find out more about this competition and apply.